Amarin Corp Plc (AMRN)

[rosemountbomber]

Sleven just spitballing and wondering.  Hikma infringed not only via its label but also via its marketing, and statements.  So are the last two items what the other Generics think are saving them?   I couldn't quickly find the sales breakdown of V between the various Generics but I was trying to see if many of the other Generics are close to the same sales of V as Hikma, then either the label plays the largest role or other facets of our healthcare system conspire to do this.  We all know PBMs are constantly trying to boost profits and doctors are known to suggest cheaper avenues for patients.